Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions
NCT03582826
Body Odor, Digestive System Diseases
Miami, Florida, United States
View Trial DetailsNCT Number: NCT02683876
The purpose of this study is to identify metabolic signatures associated with malodor conditions. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore if conditions leading to malodor can be screened by metabolomic profiling of urine samples.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The Metabolomics Innovation Centre, Edmonton, Alberta, Canada
In this study, metabolite profiling analysis will be carried out on urine samples of individuals with malodor conditions related to metabolism inefficiencies. Metabolic profiles will be identified using the metabolomics equipment located in the NMR, HPLC and MS facilities of the Metabolomics Innovation Centre (TMIC). Multivariate statistical analyses will be used, as well as other approaches to mine complex data from heterogeneous sources.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: time from diagnostic urine sample collection to dispatch of results
The investigators would like to validate if urine metabolomic profiling can be used for identifying key metabolomic signatures associated with malodor.
Differences in metabolite concentrations will be measured by mass spectrometry, to compare urine samples from individuals with malodor issues, and age-matched healthy controls.
Time frame: time from sample collection to notification of results and follow-up needed.
The investigators will comprehensively analyze the ability of metabolite levels to discriminate frequent and severe from less severe malodor symptoms. The severity of the disease was assessed trough interviews (frequency of key symptoms) and prior laboratory tests.
Mebo Research, Inc.
Other
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03582826
Body Odor, Digestive System Diseases
Miami, Florida, United States
View Trial DetailsNCT02692495
Body Odor, Dysbiosis
London, England, United Kingdom
View Trial DetailsNCT06127823
Diabetes Mellitus, Diabetes, Gestational
Herlev, Denmark
View Trial DetailsNCT04451499
Bariatric Surgery Candidate, Nutritional and Metabolic Diseases
Tel Aviv, Israel
View Trial Details